P. Sarobe

B. Sangro, J. Quiroga, J. Herrero, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.

Lieping Chen, J. Prieto, I. Melero, 2005, Vaccine.

Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L

J. Prieto, E. Huarte, J. Lasarte, 2013, Oncoimmunology.

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis.

J. Prieto, C. Leclerc, J. Lasarte, 2010, Vaccine.

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.

J. Prieto, J. Lasarte, P. Sarobe, 1999, International immunology.

Abnormal Priming of CD 4 T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E 1 Proteins

J. Prieto, J. Lasarte, P. Sarobe, 2002 .

Cells as vehicles for therapeutic genes to treat liver diseases

J. Prieto, C. Qian, P. Sarobe, 2008, Gene Therapy.

Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy.

A. Lujambio, P. Sarobe, 2022, Journal of hepatology.

Pre-selection of PD-1+ Tumor-Infiltrating CD8+ T cells improves the efficacy of adoptive T-cell Therapy

Spain, S. Hervás-Stubbs, J. Lasarte, 2018 .

The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes

F. Guillén-Grima, S. Hervás-Stubbs, J. Lasarte, 2020, British Journal of Cancer.

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation

J. Prieto, J. Oyarzábal, P. Coffer, 2015, The Journal of Immunology.

Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice

O. Rabal, S. Hervás-Stubbs, J. Lasarte, 2018, Front. Immunol..

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

J. Prieto, C. Leclerc, P. Berraondo, 2012, International journal of cancer.

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.

J. Prieto, B. Sangro, E. Huarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.

J. Prieto, E. Huarte, J. Lasarte, 2001, Journal of hepatology.

Tim-3 expression in tumour-associated macrophages: a new player in HCC progression

P. Sarobe, T. Flecken, 2015, Gut.

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

J. Prieto, E. Huarte, J. Lasarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.

R. Buckanovich, R. Stan, E. Huarte, 2008, Cancer research.

Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen

J. Prieto, J. Lasarte, E. Celis, 2004, Clinical Cancer Research.

Lymphocytes from Carcinoembryonic Antigen Identification of an Antigenic Epitope for Helper T Updated Version

J. Prieto, B. Sangro, E. Huarte, 2002 .

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10

P. Sarobe, Diana Llópiz, Leyre Silva, 2018, Front. Immunol..

Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.

J. Prieto, C. Leclerc, J. Lasarte, 2012, Vaccine.

TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity.

Flor Navarro, S. Hervás-Stubbs, J. Lasarte, 2021, Cancer letters.

Vaccine Efficacy in Mice Regulatory T Cell Activity and Improves A Peptide Inhibitor of FOXP3 Impairs

J. Prieto, J. Lasarte, J. Riezu-Boj, 2010 .

In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF- 1

J. Lasarte, J. Riezu-Boj, P. Sarobe, 2008 .

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine‐induced liver damage

P. Boya, J. Prieto, J. Lasarte, 2003 .

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage.

P. Boya, J. Prieto, J. Lasarte, 2003, Hepatology.

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

J. Berzofsky, D. Stroncek, J. Lasarte, 2020, Cancer letters.

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

P. Sarobe, Diana Llópiz, M. M. Soldevilla, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial Cells

J. Prieto, V. Segura, E. Larrea, 2009, Journal of Virology.

MAGE antigens: therapeutic targets in hepatocellular carcinoma?

I. Melero, G. Mazzolini, P. Sarobe, 2004, Journal of hepatology.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

J. Prieto, E. Larrea, P. Gastaminza, 2013, Gut.

Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2011, Cancer research.

Monocyte‐derived dendritic cells from HCV‐infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)

J. Prieto, J. Lasarte, A. Zabaleta, 2008, Journal of viral hepatitis.

The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo1

J. Prieto, C. Leclerc, S. Hervás-Stubbs, 2007, The Journal of Immunology.

Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice.

J. Prieto, G. González-Aseguinolaza, Á. Vales, 2010, Vaccine.

Engineered promiscuous T helper peptides for the induction of immune responses.

J. Lasarte, A. Zabaleta, P. Sarobe, 2007, Molecular immunology.

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2007, Cytokine.

Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection

J. Heeney, J. Prieto, T. Wakita, 2007, Journal of Virology.

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2009, Journal of hepatology.

The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ

J. Prieto, I. Melero, J. Pérez-Gracia, 2007, International journal of cancer.

Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

B. Sangro, J. Quiroga, M. Ávila, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Getting insights into hepatocellular carcinoma tumour heterogeneity by multiomics dissection

F. Corrales, P. Sarobe, 2019, Gut.

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Ibon Tamayo, S. Hervás-Stubbs, J. Lasarte, 2022, Frontiers in Immunology.

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

J. Prieto, I. Melero, A. Arina, 2003, Journal of Virology.

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.

J. Prieto, Á. Vales, J. Lasarte, 2002, Vaccine.

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance

J. Prieto, G. Missale, J. Lasarte, 2016, Journal of medical virology.

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Flor Navarro, S. Hervás-Stubbs, J. Lasarte, 2022, Frontiers in Immunology.

Synthesis and anti-HIV-1 activities of new pyrimido[5,4-b]indoles.

J. Lasarte, F. Borrás, P. Sarobe, 1999, Farmaco.

Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives.

J. Lasarte, F. Borrás, C. San Martín, 1997, Drug design and discovery.

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

J. Prieto, B. Sangro, J. Lasarte, 2015, Molecular therapy. Methods & clinical development.

Immune monitoring of immunosuppression withdrawal of liver transplant recipients.

B. Sangro, J. Quiroga, J. Lasarte, 2015, Transplant immunology.

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.

C. Wellbrock, I. Arozarena, K. Breckpot, 2017, Cell reports.

Epitope Enhancement of a CD4 HIV Epitope toward the Development of the Next Generation HIV Vaccine1

Takahiro Okazaki, Pablo Sarobe, J. Berzofsky, 2006, The Journal of Immunology.

Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

J. Prieto, J. Cullen, S. Hervás-Stubbs, 1997, Journal of hepatology.

T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.

J. Prieto, J. Cullen, S. Hervás-Stubbs, 2001, Journal of Hepatology.

Overcoming class II-linked non-responsiveness to hepatitis B vaccine.

J. Prieto, C. Berasain, S. Hervás-Stubbs, 1994, Vaccine.

Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins

J. Prieto, J. Lasarte, P. Sarobe, 2002, Journal of Virology.

[New therapies for hepatitis C].

J. Prieto, P. Sarobe, L. Gil-Guerrero, 2006, Medicina clinica.

Short Pc)per Overcoming class II-linked non-responsiveness to hepatitis B vaccine

C. Berasain, J. Lasarte, P. Sarobe, 1994 .

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

F. Prósper, G. González-Aseguinolaza, J. Lasarte, 2021, Emerging microbes & infections.

Specific and general HLA-DR binding motifs: comparison of algorithms.

E. Huarte, J. Lasarte, J. Riezu-Boj, 2000, Human immunology.

Advances in immunotherapy for hepatocellular carcinoma

B. Sangro, I. Melero, S. Hervás-Stubbs, 2021, Nature Reviews Gastroenterology & Hepatology.

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

S. Hervás-Stubbs, P. Sarobe, Diana Llópiz, 2022, International journal of molecular sciences.

Neoantigens as potential vaccines in hepatocellular carcinoma

L. Buonaguro, B. Sangro, S. Hervás-Stubbs, 2022, Journal for ImmunoTherapy of Cancer.

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

V. Trochon-Joseph, B. Sangro, J. Lasarte, 2018, Cancer Immunology, Immunotherapy.

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

J. Prieto, J. Lasarte, J. Esteban, 2011, Hepatology.

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

J. Prieto, J. Lasarte, J. Esteban, 2007, Antiviral research.

The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo1

J. Prieto, C. Leclerc, S. Hervás-Stubbs, 2007, The Journal of Immunology.

Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects

J. Prieto, J. Lasarte, A. Zabaleta, 2007, Cancer Immunology, Immunotherapy.

Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy

J. Prieto, P. Berraondo, J. Lasarte, 2009, International journal of cancer.

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

I. Fabregat, E. Gonzalez-Sanchez, M. Ávila, 2021, Cancers.

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

B. Sangro, J. Lasarte, A. Lujambio, 2020, Cancers.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

J. Prieto, B. Sangro, I. Melero, 2013, Journal of hepatology.

Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis.

J. Lasarte, J. Riezu-Boj, P. Sarobe, 2011, Cytokine.

Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

J. Berzofsky, V. Engelhard, P. Sarobe, 1998, The Journal of clinical investigation.

In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes.

J. Prieto, J. Lasarte, P. Sarobe, 1995, Research in immunology.

Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV‐1 infectivity

J. Prieto, C. Berasain, S. Hervás-Stubbs, 1995, European journal of immunology.

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment.

J. Prieto, J. Lasarte, M. Civeira, 1996, Journal of hepatology.

Improved dendritic cell‐based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

J. Pawlotsky, J. Prieto, J. Lasarte, 2011, Hepatology.

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

José L Carrascosa, Teresa Lozano, Pablo Sarobe, 2017, Oncoimmunology.

A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice

J. Prieto, J. Lasarte, J. Riezu-Boj, 2010, The Journal of Immunology.

Polarity of immunogens: implications for vaccine design

J. Lasarte, P. Sarobe, F. Borrás-Cuesta, 1990, European journal of immunology.

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.

J. Prieto, J. Lasarte, P. Sarobe, 1999, International immunology.

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct.

J. Prieto, J. Lasarte, P. Sarobe, 1992, Cellular immunology.

Carcinoembryonic antigen as a target to induce anti-tumor immune responses.

E. Huarte, J. Lasarte, P. Sarobe, 2004, Current cancer drug targets.

CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination 1

J. Prieto, I. Melero, J. Lasarte, 2003, The Journal of Immunology.

Identification of HLA‐B27–restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

J. Prieto, G. Brem, E. Huarte, 2002, International journal of cancer.

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

J. Prieto, O. Rabal, J. Oyarzábal, 2017, Oncotarget.

Immunization with a tumor‐associated CTL epitope plus a tumor‐related or unrelated Th1 helper peptide elicits protective CTL immunity

J. Prieto, I. Melero, J. Lasarte, 2001, European journal of immunology.

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

J. Lasarte, M. Esteban, J. García-Arriaza, 2023, Frontiers in Immunology.

A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo

J. Prieto, J. Lasarte, P. Sarobe, 2013, BioMed research international.

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses.

J. Prieto, J. Lasarte, P. Sarobe, 2003, International immunology.

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

P. Romero, J. Carrascosa, S. Hervás-Stubbs, 2020, Journal for immunotherapy of cancer.

Induction of Multiepitopic and Long‐Lasting Immune Responses Against Tumour Antigens by Immunization with Peptides, DNA and Recombinant Adenoviruses Expressing Minigenes

J. Prieto, E. Huarte, J. Lasarte, 2009, Scandinavian journal of immunology.

Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination

J. Lasarte, P. Sarobe, Fernando Aranda, 2016, Oncoimmunology.

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

J. San Miguel, J. Martinez-Climent, F. Prósper, 2023, Nature Medicine.

Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies

S. Hervás-Stubbs, J. Lasarte, A. Lujambio, 2019, Frontiers in Immunology.

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.

J. Prieto, M. Ávila, C. Berasain, 2009, Journal of hepatology.

Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

J. Lasarte, F. Borrás, Arantxa González, 2005, Journal of hypertension.

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

S. Hervás-Stubbs, J. Lasarte, E. Guruceaga, 2016, Oncotarget.

A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.

J. Lasarte, Arantxa González, P. Sarobe, 2008, Cardiovascular research.

Victor Epithelial Cells Immunostimulatory Functions in Liver Effects of Type I Interferon and Activates Oncostatin M Enhances the Antiviral

J. Prieto, V. Segura, E. Larrea, 2009 .

HIV Vaccine toward the Development of the Next Generation Epitope Enhancement of a CD4 HIV Epitope

J. Berzofsky, K. Thomas, P. Sarobe, 2012 .

Epitope Enhancement of a CD 4 HIV Epitope toward the Development of the Next Generation HIV Vaccine 1

J. Berzofsky, D. Schwartz, P. Sarobe, 2006 .

Generation HIV Vaccine toward the Development of the Next Epitope Enhancement of a CD4 HIV Epitope

J. Berzofsky, P. Sarobe, C. D. Pendleton, 2006 .

The DSS LOGDIS Optimizes Delivery Routes for FRILAC's Frozen Products

Javier Faulin, Pablo Sarobe, Jorge Simal, 2005, Interfaces.

A phase I clinical trial of intratumoral injection of adenovirus encoding interleukin-12 in patients with hepatocellular carcinoma and other advanced gastrointestinal tumors

J. Prieto, B. Sangro, J. Quiroga, 2003 .

Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

J. Prieto, B. Sangro, I. Melero, 2012 .

Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

J. Lasarte, M. Civeira, P. Sarobe, 1991, European journal of immunology.

Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma.

S. Hervás-Stubbs, J. Lasarte, J. Bilbao, 2019, Journal of vascular and interventional radiology : JVIR.

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant.

J. Guillaume, J. Lasarte, J. Guillet, 1991, Biologicals : journal of the International Association of Biological Standardization.

B cell epitopes of HIV type 1 p24 capsid protein: a reassessment.

J. Hoebeke, J. Lasarte, P. Sarobe, 1996, AIDS research and human retroviruses.

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.

M. Ávila, C. Berasain, M. Santamaría, 2009, Journal of hepatology.

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.

J. Lasarte, P. Sarobe, F. Borrás-Cuesta, 1994, Journal of acquired immune deficiency syndromes.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

B. Sangro, J. Lasarte, E. Larrea, 2011, Journal of hepatology.

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

B. Sangro, J. Quiroga, J. Herrero, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.

H. Matthaei, J. Lasarte, P. Sarobe, 2023, Immunological investigations.

Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma

J. Bayo, G. Mazzolini, M. Rizzo, 2011, Cancer Immunology, Immunotherapy.

Identification of neoantigen-reactive T cells in hepatocellular carcinoma: implication in adoptive T cell therapy

B. Sangro, Ibon Tamayo, S. Hervás-Stubbs, 2020, Journal of Hepatology.

Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells.

J. Lasarte, E. Larrea, P. Sarobe, 1993, Research in immunology.

Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives.

J. Lasarte, F. Borrás, P. Sarobe, 1997, Drug design and discovery.

Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine.

J. Lasarte, M. Civeira, P. Sarobe, 1996, AIDS research and human retroviruses.